 Compliance clinical trials nonbronchodilator antiasthma medications electronic monitoring device patient compliance clinical trials new nonbronchodilator antiasthma drugs Compliance poor similar trials Patients study drug mean days trial days underuse overuse Underuse mean days mean days days patients activations device time patients multiple simultaneous activations separate days patients noncompliant study Multiple simultaneous activations underuse days followup visits possibility duplicity Overall compliance valid conclusions efficacy drugs patients